Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion type Assertion NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_head.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion description "[Furthermore, we found that miR-126 expression was associated with tumor cell dedifferentiation and lymph node metastasis, miR-16-2 was associated with lymph node metastasis, and miR-195p was associated with higher pathologic disease stages in patients with esophageal adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_provenance.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion evidence source_evidence_literature NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_provenance.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion SIO_000772 20309880 NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_provenance.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion wasDerivedFrom befree-2016 NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_provenance.
- NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_assertion wasGeneratedBy ECO_0000203 NP801702.RAhI1U3i0Dq4pb7CfUuwB-3XdNU42sBVaUdZ7Ay3zGGws130_provenance.